Abstract
Background: The rise in antimicrobial resistance, caused by the production of biofilms by bacteria, is a significant concern in the field of healthcare. Nanoemulsion technology presents itself as a viable alternative in the quest to circumvent antibiotic resistance in pathogenic bacteria.
Objective: The aim of this research was to form a sustainable nanoemulsion from Z. multiflora, and evaluate its antibacterial and anti-biofilm activities against the clinical isolates of Pseudomonas aeruginosa, Proteus mirabilis, and Staphylococcus aureus.
Materials and Methods: Bioactive compounds of the oil were identified using GC-MS. Zataria multiflora essential oil (ZMEO) nanoemulsion was formulated as a water-dispersible nanoemulsion with a diameter of 184.88 ± 1.18 nm. The antibacterial and antibiofilm activities of the essential oil in both pure and nanoemulsion forms were assessed against pathogenic bacteria causing hospital-acquired infections using minimal inhibitory concentrations (MICs) and the microtiter method, respectively.
Results: The main constituents were found to be linalool (78.66 %), carvacrol (14.25 %), and α- pinene (4.53%). Neither ZMEO nor the emulsified ZMEO showed any antimicrobial activity. However, ZMEO exhibited a low inhibition of biofilm formation by P. mirabilis, S. aureus, and P. aeruginosa. The most promising finding was that when the emulsified ZMEO was present at a concentration of 750 μg/mL, it significantly reduced biofilm formation by the aforementioned bacteria to 39.68% ± 2.62, 56.54% ± 3.35, and 59.60% ± 2.88, respectively. This result suggests that ZMEO nanoemulsion has the potential to effectively disrupt persistent biofilms and enhance the penetration of antimicrobial agents into the biofilm matrix.
Conclusion: In conclusion, the study provides evidence supporting the use of ZMEO nanoemulsion as a potential treatment option for combating biofilm-related infections caused by Pseudomonas aeruginosa, Proteus mirabilis, and Staphylococcus aureus. Further research is warranted to explore the practical application of the proposed essential oil in clinical settings.
[http://dx.doi.org/10.3389/fmicb.2016.00592] [PMID: 27199924]
[http://dx.doi.org/10.1002/bit.27760] [PMID: 33748946]
[http://dx.doi.org/10.3389/fmicb.2020.566325] [PMID: 33193155]
[http://dx.doi.org/10.1016/j.jep.2012.12.018] [PMID: 23266333]
[http://dx.doi.org/10.1016/j.fct.2010.03.025] [PMID: 20332011]
[http://dx.doi.org/10.1055/s-2006-957707] [PMID: 17252397]
[PMID: 21454174]
[http://dx.doi.org/10.1016/j.foodres.2008.07.018]
[http://dx.doi.org/10.1111/jfs.12476]
[http://dx.doi.org/10.1016/j.lwt.2006.07.007]
[http://dx.doi.org/10.1016/j.foodcont.2006.03.002]
[http://dx.doi.org/10.1007/s00580-011-1287-3]
[http://dx.doi.org/10.1515/hepo-2017-0015]
[PMID: 32210484]
[http://dx.doi.org/10.1016/j.foodcont.2006.04.002]
[http://dx.doi.org/10.1016/j.foodchem.2015.07.139] [PMID: 26471573]
[http://dx.doi.org/10.1002/jobm.201200060] [PMID: 22961665]
[http://dx.doi.org/10.1016/j.lwt.2020.109669]
[http://dx.doi.org/10.1016/j.jbiotec.2016.07.005] [PMID: 27416793]
[http://dx.doi.org/10.4103/0973-1296.75902] [PMID: 21472080]
[http://dx.doi.org/10.1080/0972060X.2014.983994]
[http://dx.doi.org/10.1111/jam.15171] [PMID: 34077580]
[http://dx.doi.org/10.3390/antibiotics12030545] [PMID: 36978412]
[http://dx.doi.org/10.1016/j.fbio.2019.01.018]
[http://dx.doi.org/10.3390/molecules27206874] [PMID: 36296467]
[http://dx.doi.org/10.1007/s12038-019-9868-4] [PMID: 31180065]
[http://dx.doi.org/10.1111/ijfs.13438]
[http://dx.doi.org/10.1016/j.lwt.2017.02.037]
[http://dx.doi.org/10.1016/j.lwt.2018.04.018]
[http://dx.doi.org/10.1016/j.micpath.2018.03.043] [PMID: 29581028]